Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis

Tissue Antigens

Volumn 69, Issue 4, 2007, Pages 305-312

  Beretta, L ^a   Cappiello, F ^a   Barili, M ^a   Scorza, R ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Interleukin 10; Polymorphism; Systemic sclerosis

Indexed keywords

INTERLEUKIN 10;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC SCLEROSIS;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; ITALY; MALE; MIDDLE AGED; MODELS, GENETIC; PHENOTYPE; POLYMORPHISM, GENETIC; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

EID: 33947604076     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2007.00811.x     Document Type: Article

References (39)

1. Silver RM. Clinical aspect of systemic sclerosis (scleroderma). Ann Rheum Dis 1991: 50: 854-61.
2. Assassi S, Tan FK. Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays. Curr Opin Rheumatol 2005: 17: 761-7.
3. Tamby MC, Chanseaud Y, Guillevin L, Mouthon L. New insights into the pathogenesis of systemic sclerosis. Autoimmun Rev 2003: 2: 152-7.
4. Fatini C, Guiducci S, Abbate R, Matucci-Cerinic M. Vascular injury in systemic sclerosis: angiotensin-converting enzyme insertion/deletion polymorphism. Curr Rheumatol Rep 2004: 6: 149-55.
5. Granel B, Chevillard C, Allanore Y et al. Evaluation of interleukin 13 polymorphisms in systemic sclerosis. Immunogenetics 2006: 58: 693-9.
6. Beretta L, Cappiello F, Barili M, Bertolotti F, Scorza R. T-889C IL-1alpha promoter polymorphism influences the response to oral cyclophosphamide in scleroderma patients with alveolitis. Clin Rheumatol 2007: 26: 88-91.
7. Kawaguchi Y, Tochimoto A, Ichikawa N et al. Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population. Arthritis Rheum 2003: 48: 186-92.
8. Fickenscher H, Hor S, Kupers H, Knappe A, Wittmann S, Sticht H. The interleukin-10 family of cytokines. Trends Immunol 2002: 23: 89-96.
9. H2 paradigm. Nat Rev Immunol 2004: 4: 583-94.
10. McGaha TL, Bona CA. Role of profibrogenic cytokines secreted by T cells in fibrotic processes in scleroderma. Autoimmunity Rev 2002: 1: 174-81.
11. Hasegawa M, Fujimoto M, Takehara K, Sato S. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis. J Dermatol Sci 2005: 39: 1-7.
12. Kucharz EJ, Brzezinska-Wcislo L, Kotulska A, Gasiorowska-Kielkowska W, Gozdzik J. Elevated serum level of interleukin-10 in patients with systemic sclerosis. Clin Rheumatol 1997: 16: 638-9.
13. Dziankowska-BartkowiakB,ZalewskaA, Sysa-JedrzejowskaA. Duration of Raynauds phenomenon is negatively correlated with serum levels of interleukin 10 (IL-10), soluble receptor of interleukin 2 (sIL2R), and sFas in systemic sclerosis patients. Med Sci Monit 2004: 10: CR202-8.
14. Matsushita T,HasegawaM,HamaguchiY,TakeharaK,Sato S. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. J Rheumatol 2006: 33: 275-84.
15. Sato S, Hasegawa M, Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci 2001: 27: 140-6.
16. Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 1992: 148: 3618-23.
17. Suarez A, Castro P, Alonso R, Mozo L, Gutierrez C. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 2003: 75: 711-17.
18. Yilmaz V, Yentur SP, Saruhan-Direskeneli G. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 2005: 30: 188-94.
19. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997: 24: 1-8.
20. Perrey C, Pravica V, Sinnott PJ, Hutchinson IV. Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report. Transpl Immunol 1998: 6: 193-7.
21. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutics Criteria Committee. Arthritis Rheum 1980: 23: 581-90.
22. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subset and pathogenesis. J Rheumatol 1988: 15: 202-5.
23. White B, Bauer EA, Goldsmith LA, Hochberg MC, Katz LM, Korn JH. Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. Sem Arthritis Rheum 1995: 38: 351-60.
24. Tseng LH, Chen PJ, Lin MT et al. Simultaneous genotyping of single nucleotide polymorphisms in the IL-1 gene complex by multiplex polymerase chain reaction-restriction fragment length polymorphism. J Immunol Methods 2002: 267: 151-6.
25. Scassellati C, Zanardini R, Squitti R et al. Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease. Neurosci Lett 2004: 356: 119-22.
26. Hoffmann SC, Stanley EM, Darrin Cox E et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28- stimulated peripheral blood lymphocytes. Transplantation 2001: 72: 1444-50.
27. Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 2001: 28: 2454-9.
28. Hesselstrand R, Scheja A, Shen GQ, Wiik A, Akesson A. The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford) 2003: 42: 534-40.
29. Nishioka K, Katayama I, Kondo H et al. Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). Scleroderma Research Committee Japan. J Dermatol 1996: 23: 677-82.
30. Banning U, Krutmann J, Korholz D. The role of IL-4 and IL-12 in the regulation of collagen synthesis by fibroblasts. Immunol Invest 2006: 35: 199-207.
31. McGaha TL, Le M, Kodera T et al. Molecular mechanisms of interleukin-4-induced up-regulation of type I collagen gene expression in murine fibroblasts. Arthritis Rheum 2003: 48: 2275-84.
32. Mavalia C, Scaletti C, Romagnani P et al. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 1997: 151: 1751-8.
33. Scala E, Pallotta S, Frezzolini A et al. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 2004: 138: 540-6.
34. Giacomelli R, Cipriani P, Lattanzio R et al. Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease. Clin Exp Immunol 1997: 108: 42-6.
35. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994: 37: 75-83.
36. Douvas A. Does Sc1-70 modulate collagen production in systemic sclerosis? Lancet 1988: 2: 475-7.
37. Henault J, Robitaille G, Senecal JL, Raymond Y. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients. Arthritis Rheum 2006: 54: 963-73.
38. Hesselstrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998: 57: 682-6.
39. Crilly A, Hamilton J, Clark CJ, Jardine A, Madhok R. Analysis of the 5′ flanking region of the interleukin 10 gene in patients with systemic sclerosis. Rheumatology (Oxford) 2003: 42: 1295-8.